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Abstract
A solitary, elongated cluster of parvalbumin-immunoreactive neurons has been previously observed in the rodent ventrolateral
hypothalamus. However, the function of this so-called PV1 nucleus is unknown. In this article, we report the results of an unbiased,
broad and in-depth molecular characterization of this small, compact group of neurons. The Allen Brain Atlas database of in situ
hybridization was screened in order to identify genes expressed in the PV1-nucleus-containing area of the hypothalamus, and those
that might be co-expressed with parvalbumin. Although GABA is the principal neurotransmitter in parvalbumin-expressing cells in
various other brain areas, we found that PV1 neurons express the vesicular glutamate transporter (VGlut) VGlut2-encoding gene
Slc17a6 and are negative for the glutamic acid decarboxylase 1 (GAD1) gene. These cells also express the mRNA for the
neuropeptides Adcyap1 and possibly Nxph4, express several types of potassium and sodium channels, are under the control of the
neurotransmitter acetylcholine, bear receptors for the glial-derived neurotrophic factor, and produce an extracellular matrix rich in
osteopontin. The PV1 nucleus is thus composed of glutamatergic nerve cells, expressing some typical markers of long-axon,
projecting neurons (e.g. VGlut2), but also co-expressing genes typical of short-axon GABA neurons (e.g. a variety of potassium
channels). Hence, neurons of the PV1 nucleus combine physiological characteristics of interneurons with those of projection neurons.
Introduction
The lateral hypothalamic area (LHA) is a large and heterogeneous
region, containing several distinct nuclear groups. Although the LHA
was historically described as a ‘feeding center’, its connectivity with
autonomic, sympathetic and mesolimbic systems indicates that it
regulates the physiological responses to a range of stimuli (such as
food, drugs or stress) (reviewed in Berthoud & Mu¨nzberg, 2011).
Interest in the LHA has recently re-emerged with the discovery of the
orexin ⁄ hypocretin system and its importance in regulating the
sleep ⁄wake cycle (reviewed in Sakurai et al., 2010; Leinninger,
2011). The complex structural organization of the LHA (dense and
complex array of cell groups and ﬁber pathways) hampers an analysis
of the anatomical to functional relationships. Such an analysis would
be aided by a better characterization of the neurotransmitter and
neuropeptide content of its neurons.
The EF-hand calcium-binding protein parvalbumin (Pvalb) is
strongly expressed in various regions of the postnatal rodent brain,
including the cortex, hippocampus, thalamus, midbrain and cerebel-
lum (Celio, 1990; Schwaller, 2009). On the basis of Ca2+-binding and
release kinetics, Pvalb acts as a slow calcium buffer, playing important
roles in modulating intracellular calcium dynamics in neurons
(Baimbridge et al., 1992; Schwaller, 2009). A solitary cluster of
Pvalb-immunoreactive neurons, referred to as the PV1 nucleus, has
been observed in the ventrolateral division of the medial forebrain
bundle of the rodent hypothalamus (Celio, 1990). These neurons are
orientated horizontally, and have a bipolar or multipolar form (Meszar
et al., 2011). Unlike Pvalb-immunoreactive neurons in most other
regions of the brain, those of the PV1 nucleus lack the GABA-
synthesizing enzyme GAD and GABA itself, but are immunoreactive
for glutamate (Meszar et al., 2011).
Topographical mapping of the gene expression patterns in the
mammalian central nervous system is crucial for an understanding of
the functional networks. During the past few years, research in the
ﬁeld of neuroscience has entered a new era with the release of in situ
hybridization (ISH) data at the genomic scale, such as appear in the
Allen Brain Atlas (ABA) for mouse gene expression (Lein et al.,
2007). Indeed, such data provide powerful tools allowing a systematic
analysis of particular neuroanatomical structures at the gene expres-
sion level (D’Souza et al., 2008; Olszewski et al., 2008; Thompson
et al., 2008; Dong et al., 2009).
In this context, identifying genes co-expressed with Pvalb may yield
further insight into the evolution and function of the PV1 nucleus. The
microarray approach has proved to be an efﬁcient method for genome-
wide expression proﬁling, but it is a challenging technique for
structures that embrace only a small number of cells, such as the PV1
nucleus. Therefore, we undertook a genome-scale ISH analysis to
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identify genes co-expressed with Pvalb in PV1 neurons. For this
purpose, the ABA database was screened to pinpoint potential
candidates, and ISH was used to demonstrate co-expression with
Pvalb.
Materials and methods
Animals
C57BL ⁄ 6J mice were used in this study. Animals (20–30 g in weight)
were anesthetized with pentobarbital (100 mg ⁄ kg), and perfused with
ice-cold 0.9% NaCl. Brains were then removed, immediately frozen
on dry ice and stored at )70 C until use. The project was approved by
the veterinary committee for animal research of the Canton of
Fribourg, Switzerland.
In situ hybridization and immunostaining
Digoxygenin-labeled RNA probes were prepared following recom-
mendations from Roche (DIG application manual for non radioactive
in situ hybridization, 3rd edn). Total RNA from mouse brain (Zyagen,
San Diego, CA, USA) was reverse transcribed using oligodT as
primer, and this reaction mixture was used as the template for
polymerase chain reactions using primers speciﬁc for each of the
genes tested, as described in the ABA (http://www.brain-map.org/).
Forward and reverse primers were ﬂanked by T3 and SP6 RNA
polymerase core promoter sequences, respectively (T3, AAT-
TAACCCTCACTAAAGGG and SP6, GCGATTTAGGTGAC-
ACTATAG). All primers were purchased from Microsynth
(Balgach, Switzerland). Antisense and sense RNA probes were
prepared from each speciﬁc polymerase chain reaction template by
in vitro transcription with either SP6 or T3 RNA polymerase and
digoxygenin-labeled UTP (Roche Applied Science, Switzerland).
Sense probes were used as the negative control of the hybridization
procedure. The quality and yields of the probes were estimated on
agarose gel. For Pvalb RNA probe, polymerase chain reaction was
performed directly using mouse Pvalb full-length cDNA (purchased
from ImaGenes, Berlin, Germany) as template, using the Pvalb-
speciﬁc primers described in the ABA.
For Macaca fascicularis probes, the following primers were used in
reverse transcription–polymerase chain reaction experiments using
total RNA from Macaca brain (a gift from Dr F. Raulf, Novartis,
Basel, Switzerland): Serpini1 (forward, ATGTGATGAAAATTG-
CCAAT; reverse, ATTCCTGAGACAGCAGCAGC) and Slc17a7
(forward, ATGGGCCCCACCCTTAGAAC; reverse, CTAAACT-
TCGTGAGGGGGTT). Primers were ﬂanked by a T3 (forward) and
SP6 (reverse) RNA polymerase core promoter sequence as described
for mouse probes. Probes were made exactly as described for mouse.
The 12–14 lm coronal brain cryosections were prepared on
Superfrost gold slides (Medite, Nunningen, Switzerland), and stored
at )70 C until use. ISH was performed essentially following the
recommendations of Roche. Brieﬂy, sections were ﬁxed in 4%
paraformaldehyde in phosphate-buffered saline for 20 min at 4 C,
rinsed in phosphate-buffered saline, and incubated for 10 min in 0.1 m
triethanolamine containing 0.25% acetic anhydride. Sections were
sequentially incubated in phosphate-buffered saline ⁄ 0.1 m gly-
cine ⁄ 0.3% Triton-X100 for 5 min, phosphate-buffered saline for
5 min, 0.1 m Tris, pH 7.5 ⁄ 50 mm EDTA containing 1 lg ⁄mL
proteinase K at 37 C for 3–5 min, and postﬁxed for 5 min in 4%
paraformaldehyde (PFA). Sections were prehybridized for 30 min at
57 C in 50% formamide ⁄ 5· saline sodium citrate buffer (SSC), then
hybridized for 16 h at 57 C with the respective probes in buffer
containing 50% formamide ⁄ 5· SSC ⁄ 10% Dextran sulfate ⁄ 1· Den-
hardt’s solution ⁄ 2.5 mg ⁄mL Torula RNA. Sections were washed at
the hybridization temperature in, respectively, 2· SSC, 1· SSC and
0.2· SSC, 20 min each, then incubated for 30 min in buffer 1 (0.1 m
Tris, pH 7.5 ⁄ 0.15 m NaCl) containing 0.1% Triton-X100 and 1%
Roche blocking reagent. Alkaline-phosphatase-conjugated anti-digo-
xygenin (Roche Applied Science) was applied for 2 h. Sections were
washed three times for 15 min in buffer 1, and 15 min in buffer 2
(0.1 m Tris, pH 9.5 ⁄ 0.1 m NaCl ⁄ 50 mm MgCl2). Detection was
performed with nitroblue tetrazolium (NBT)-5-bromo-4-chloro-3¢-
indolylphosphate (BCIP) (Roche Applied Science) in buffer 2, in the
presence of 100 mm levamisole.
Immunostaining with rabbit anti-Pvalb (Swant, Marly, Switzerland)
on 20 lm coronal sections was performed following the standard
protocol.
Informatics
allenminer (v1.5; Davis & Eddy, 2009) was used to retrieve three-
dimensional expression ﬁles from the ABA (Lein et al., 2007) at
100 lm resolution (XPR ﬁles; n = 21 741) and smoothed 200 lm
resolution (SVA ﬁles; n = 24 858) formats (January 2010). A region
of interest encompassing the PV1 nucleus was ﬁrst deﬁned in the ABA
coordinate system by specifying those voxels in a cuboid [coronal
x = (56,71), horizontal y = (60, 67), sagittal z = (42, 48)] that did not
overlap with the tuberal nucleus, subthalamic nucleus, or anterior
hypothalamic nucleus, as deﬁned by the ABA reference atlas. One
layer of edge voxels that bordered the tuberal nucleus, subthalamic
nucleus, or anterior hypothalamic nucleus structures was removed to
reduce the effect of mis-registration artifacts, which especially affect
small regions (Davis & Eddy, 2009), yielding a ﬁnal PV1 region of
interest containing 699 voxels (of 100 lm resolution).
allenminer queries were then performed to identify (i) genes that
are locally enriched in the PV1 region of interest, and (ii) genes whose
PV1 expression is similar to Pvalb. First, the ABA data (100 lm3
format) were evaluated for enrichment of gene expression in the PV1
region of interest relative to its local neighborhood, deﬁned by a 4-
voxel-thick shell whose PV1-bordering layer is removed (run modes
roiseparate_adjacent, roi_list, calcentropy_xpr_roi_results). Second,
the similarity of each expression dataset (200 lm format) to each
Pvalb expression series (coronal, n = 2; sagittal, n = 19) was quan-
tiﬁed by the Pearson’s correlation coefﬁcient of expression levels
across all voxels in the region of interest where expression was
registered for both genes (run mode expr_sim_query).
The accuracies of the searches were assessed using a benchmark set
of genes (n = 21) whose Pvalb co-expression was independently
determined by ISH. When thresholded to avoid all non-PV1-
expressing benchmark genes (n = 4), the enrichment and similarity
queries achieve 50 and 60% true positive rates and predict 584 and
326 PV1-expressing genes, respectively. Combining the results
predicts 843 genes, at an estimated 81% true positive rate. Requiring
detection by both search strategies predicts 67 genes, at an estimated
25% true positive rate.
Results
Computational analysis of the parvalbumin-immunoreactive
PV1 nucleus of the lateral hypothalamus
The ABA ISH database covers over 21 000 genes expressed in the
adult mouse brain (Lein et al., 2007), and is an invaluable tool for
mapping gene expression patterns in speciﬁc brain areas (D’Souza
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Table 1. List of the genes selected after screening the ABA for expression in the PV1 region
Gene Complete name Gene ontology
Adcy2 Adenylate cyclase 2 Adenylate cyclase activity
Adcyap1 Adenylate cyclase-activating polypeptide 1 Neuropeptide hormone activity
Anxa5 Annexin A5 Calcium-dependent phospholipid binding
Asb13 Ankyrin repeat and SOCS box-containing protein 13 Unknown
Cart Cocaine- and amphetamine-regulated transcript Neuropeptide ⁄ hormone activity
Cdh13 Cadherin 13 Cell adhesion
Cdh23 Cadherin 23 (otocadherin) Cell adhesion
Chrm2 Cholinergic receptor, muscarinic 2, cardiac Muscarinic acetylcholine receptor activity
Chrm3 Cholinergic receptor, muscarinic 3, cardiac Muscarinic acetylcholine receptor activity
Chrnb2 Cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal) Nicotinic acetylcholine receptor activity
Col11a1 Procollagen, type XI, alpha 1 ECM constituent
Crh Corticotropin-releasing hormone Hormone activity
Crhr1 Corticotropin-releasing hormone receptor 1 Corticotropin-releasing factor receptor activity
Crtac1 Cartilage acidic protein 1 ECM constituent
Dab1 Disabled homolog 1 Signal transduction
Fndc5 Fibronectin type III domain-containing 5 Unknown
Gad1 Glutamic acid decarboxylase 1 Glutamate decarboxylase activity
Gfra1 Glial cell line-derived neurotrophic factor family receptor alpha 1 Receptor activity
Grm1 Glutamate receptor, metabotropic 1 Glutamate receptor activity
Hcn2 Hyperpolarization-activated, cyclic nucleotide-gated K + 2 Potassium channel activity
Kcna1 Potassium voltage-gated channel, shaker-related subfamily, member 1 Potassium channel activity
Kcna2 Potassium voltage-gated channel, shaker-related subfamily, member 2 Potassium channel activity
Kcnab2 Potassium voltage-gated channel, shaker-related subfamily, beta member 2 Potassium channel activity
Kcnab3 Potassium voltage-gated channel, shaker-related subfamily, beta member 3 Potassium channel activity
Kcnc1 Potassium voltage-gated channel, Shaw-related subfamily, member 1 Potassium channel activity
Kcnc2 Potassium voltage-gated channel, Shaw-related subfamily Potassium channel activity
Kcnk1 Potassium channel, subfamily K, member 1 Potassium channel activity
Lgi2 Leucine-rich repeat LGI family, member 2 Unknown
Lhx1 LIM homeobox protein 1 Transcription factor
Limk1 LIM-domain-containing, protein kinase Protein kinase activity
Lynx1 Ly6 ⁄ neurotoxin 1 Acetylcholine receptor inhibitor activity
Lynx2 Ly6 ⁄ Plaur domain-containing 1 Acetylcholine receptor inhibitor activity
Mfap5 Microﬁbrillar-associated protein 5 ECM constituent
Nefh Neuroﬁlament, heavy polypeptide Neuroﬁlament cytoskeleton organization
Neﬂ Neuroﬁlament, light polypeptide Neuroﬁlament cytoskeleton organization
Nef3 Neuroﬁlament 3, medium Neuroﬁlament cytoskeleton organization
Nos1 Nitric oxide synthase 1, neuronal Nitric oxide synthase activity
Ntng1 Netrin G1 ECM interaction ⁄ axonogenesis
Nxph4 Neuroexophilin 4 Receptor binding
Oprm1 Opioid receptor, mu 1 Neuropeptide receptor activity
Pdyn Prodynorphin Neuropeptide ⁄ hormone activity
Penk1 Preproenkephalin 1 Opioid peptide activity
Pib5pa Phosphatidylinositol (4,5) bisphosphate 5-phosphatase, A Phosphatidylinositol-3,4,5-trisphosphate
5-phosphatase activity
Pitx2 Paired-like homeodomain transcription factor 2 Transcription factor
Plcb4 Phospholipase beta 4 Phospholipase activity
Pnkd Paroxysmal non-kinesiogenic dyskinesia Hydroxylase activity
Ret Ret proto-oncogene Transmembrane receptor protein tyrosine
kinase activity
Sall3 Sal-like 3 Transcription factor
Scg2 Secretogranin II Cytokine activity
Scn1a Sodium channel, voltage-gated, type I, alpha Sodium channel activity
Scn4B Sodium channel, type IV, beta Sodium channel activity
Scrt1 Scratch homolog 1, zinc ﬁnger protein (Drosophila) Transcription factor
Sh3gl2 SH3-domain GRB2-like 2 Unknown
Sema3f Sema domain, immunoglobulin domain, short basic domain, secreted,
(semaphorin) 3f
Chemorepellent, receptor activity
Serpini1 Serine (or cysteine) peptidase inhibitor, clade I, member 1 Peptidase inhibitor activity
Slc17a6 Solute carrier family 17, member 6 (VGlut2) Neurotransmitter (glutamate) transport
Slc17a7 Solute carrier family 17, member 7 (VGlut1) Neurotransmitter (glutamate) transport
Sncg Synuclein gamma Unknown
Spp1 Secreted phosphoprotein 1 Cytokine activity. ECM binding
Stxbp6 Syntaxin-binding protein (amysin) Vesicle-mediated transport
Tac1 Tachykinin 1 Neuropeptide activity
Tac1r Tachykinin receptor 1 Neuropeptide receptor activity
Tac2 Tachykinin 2 Neuropeptide activity
Tmem163 Transmembrane protein 163 Unknown
Trh Thyrotropin-releasing hormone Hormone activity
Uqcrh Ubiquinol-cytochrome c reductase hinge protein Ubiquinol-cytochrome c reductase activity
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et al., 2008; Olszewski et al., 2008; Thompson et al., 2008; Dong
et al., 2009). Initially, we screened the ABA database for genes that
are regionally enriched in the lateral hypothalamus, using the provided
tools: (i) the anatomic search tool focusing on the hypothalamus;
(ii) the gene ﬁnder tool of the Anatomic Gene Expression Atlas
focusing on the lateral hypothalamus; and (iii) the neuroblast tool
searching for genes with an expression pattern similar to that of Pvalb.
This ﬁrst round of screening was then followed by an automated
allenminer search (Davis & Eddy, 2009) for genes that are either
enriched in the PV1 nucleus, or that exhibit a Pvalb-like expression
pattern (see Materials and methods). From these various screens, we
chose to analyze in more detail a list of 76 candidate genes expressed
in the region containing the PV1 nucleus (see below). These can be
ontologically classiﬁed as follows (see Table 1): ion channel activity:
sodium (Scn1a, Scn4b), potassium (Hcn2, Kcna1, Kcna2, Kcnab2,
Kcnab3, Kcnc1, Kcnc2, Kcnk1); transporter activity: Slc17a6,
Slc17a7, Stxbp6, Vamp1; enzyme activity: Adcy2, Gad1, Limk1,
Nos1, Pib5pa, Plcb4, Plcxd2, Pnkd, Uqcrh; receptor activity: Chrm2,
Chrm3, Chrnb2, Crhr1, Gfra1, Grm1, Oprm1, Ret, Sema3f, Tac1r;
transcription factor activity: Lhx1, Pitx2, Sall3, Scrt1; neuropep-
tide ⁄ neurohormone activity: Adcyap1, Cart, Nxph4, Crh, Pdyn,
Penk1, Tac1, Tac2, Trh; cytoskeleton structural components: Nefh,
Nef3, Neﬂ; extracellular matrix (ECM) ⁄ cell adhesion molecules:
Cdh13, Cdh23, Col11a1, Crtac1, Mfap5, Ntgn1, Spp1,
A930038C07Rik; receptor inhibitor activity: Lynx1, Lynx2; peptidase
inhibitor activity Serpini1; miscellaneous: Anxa5, Dab1, Scg2; and
unknown function: Asb13, EFR3like, Fndc5, Lgi2, Parm1, Sh3gl2,
Sncg, Sphkap, Trnp1, Tmem163, LOC382102, 4930572J05Rik,
63304003A02Rik. The complete list of 843 candidate genes identiﬁed
with the allenminer search is available as Supporting Information
(Tables S1–S4).
Co-expression with parvalbumin in the PV1 nucleus
In the mouse brain, the PV1 nucleus can be revealed by either ISH to
Pvalb mRNA, or Pvalb immunostaining (Fig. 1) (Meszar et al., 2011).
In the ABA, it lies between coronal levels 68 and 72, forming an
elongated, longitudinally orientated structure within the lateral hypo-
thalamus (Fig. 2G) (Meszar et al., 2011). Typically, between 5 and 10
Pvalb-positive cells are visible on each coronal section (Fig. 1). We
thus reasoned that ISH on adjacent 12–14-lm-thick coronal cryosec-
tions would resolve a sufﬁcient number of cells co-expressing Pvalb
and the candidate genes. Using the selection criteria: (i) a restricted
expression pattern; (ii) a good signal-to-noise ratio of the antisense
RNA probe; and (iii) a potential functional importance, 27 of the 76
candidate genes were tested by ISH. Among them, 19 were shown
here to be co-expressed with Pvalb in the same neurons, whereas 8
were expressed by intermingling Pvalb-negative cells. The results are
presented in Figs 2 and 3, and summarized in Table 2. Figure 2
depicts the co-expression in some PV1 neurons of Pvalb with three
candidate genes, Vamp1, Adcyap1 and Slc17a6 (solute carrier family
17, member 6, encoding the glutamate transporter VGlut2). Figure 3
further presents co-expression with Pvalb of several additional genes:
Serpini1, Spp1, Pib5pa, Neﬂ, Asb13, Hcn2, Kcna2, Kcnc1 and Scn4b.
The co-expression was not apparent within all of the Pvalb-positive
cells. This incomplete co-existence was perhaps not surprising, as we
Table 1. (Continued)
Gene Complete name Gene ontology
Vamp1 Vesicle-associated membrane protein 1 Vesicle-mediated transport
LOC382102 Gene model 1125 Unknown
C920006C10Rik RIKEN cDNA C920006C10 gene (EFR3-like) Unknown
A930038C07Rik RIKEN cDNA A930038C07 gene Heparin binding, ECM organization
6330403A02Rik RIKEN cDNA 6330403A02 gene Unknown
LOC433022 Plcxd2, phosphatidylinositol-speciﬁc phospholipase C, X domain-containing 2 Phospholipase activity
2300002D11Rik RIKEN cDNA 2300002D11 gene (Trnp1) Unknown
4930544G21Rik RIKEN cDNA 4930544G21 gene (Sphkap) Unknown
4930572J05Rik RIKEN cDNA 493057J05 gene Unknown
9130213B05Rik RIKEN cDNA 9130213B05 gene (Parm1) Unknown
Given are the abbreviated and complete names, and known or proposed function (Gene Ontology) for the candidate genes selected in this study.
A B C
Fig. 1. Localization of the PV1 nucleus within the LHA in the adult mouse brain. (A) Schematic representation of brain areas at coronal level 71, according to the
Allen Reference Atlas. BLA, basolateral amygdalar nucleus; BMA, basomedial amygdalar nucleus; CP, caudoputamen; CTX, cerebral cortex; DMH, dorsomedial
hypothalamic nucleus; HY, hypothalamus; int, internal capsule; MEA, medial amygdalar nucleus; opt, optic tract; STN, subthalamic nucleus; TH, thalamus; TU,
tuberal nucleus; V3, third ventricle; VMH, ventromedial hypothalamic nucleus; ZI, zona incerta. The red point indicates the location of the PV1 nucleus at this
coronal level. (B) Pvalb mRNA expression, and (C) Pvalb immunoreactivity in the PV1 nucleus. The PV1 nucleus is highlighted with a red circle in A and B. White
arrows point to cell bodies immunoreactive for Pvalb. Scale bar: 200 lm (B), 20 lm (C). For interpretation of color references in ﬁgure legend, please refer to the
Web version of this article.
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used 12–14-lm-thick adjacent sections. Indeed, given the size of the
Pvalb-immunoreactive cell bodies (20–30 lm) (Meszar et al., 2011),
not all of the cell bodies were present on both of the adjacent sections,
explaining the lack of complete co-expression, and making a
quantiﬁcation analysis impossible with this technique. However, the
possibility that some genes are preferentially expressed in certain
neuronal subpopulations but not in others cannot be excluded. This
point will need to be clariﬁed by immunohistochemistry.
Previous immunohistochemical studies suggested that PV1 neurons
were negative for GABA, and positive for glutamate (Meszar et al.,
2011). The present study conﬁrms these observations, as these cells
express Slc17a6 ⁄VGlut2, but not Gad1. The expression of VGlut2 is
sufﬁcient to deﬁne a glutamatergic phenotype in neurons (Takamori
et al., 2000). Hence, our data indicate that Pvalb-expressing cells of the
PV1 nucleus are glutamatergic, excitatory neurons. Not surprisingly,
Slc17a7, which encodes the other vesicular glutamate transporter,
VGlut1, is not expressed in PV1 cells (Table 2). Most glutamatergic
neurons are indeed known to express one of the two transporters, and
these cell populations are probably functionally different.
The LHA harbors several neuronal subpopulations expressing
various neuropeptides, such as the orexigenic peptides galanin,
orexin ⁄ hypocretin, melanin-concentrating hormone, and the anorexi-
genic peptides neurotensin and Cart (for review, see Leinninger, 2011).
Several genes encoding hypothalamic neuropeptides were pinpointed
during our screening process. As shown in Fig. 4, although the neurons
expressing these peptides sometimes abutted on, or even intermingled
with, the PValb-expressing neurons, cells that co-expressed Pvalb and
one of the tested genes (Tac1 and Tac2, Penk1, Pdyn, Trh, and Cart)
were never revealed. Similarly, Pvalb-positive neurons of the PV1
nucleus were never observed to co-express orexin ⁄ hypocretin, galanin
or melanin-concentrating hormone (Meszar et al., 2011).
Co-expression with parvalbumin in other brain areas
Next we looked at whether these genes expressed in the PV1 nucleus
were also present in Pvalb neurons in other regions of the brain. Closer
examination at Pvalb-expressing cells in GABAergic neurons of the
reticular nucleus of the thalamus and the Pvalb-positive basket cells in
A′ B′BA
C′ C D′D
F′E′ E F
G′G H′H
Fig. 2. Expression of several genes in Pvalb-expressing cells of the PV1 nucleus. A ⁄ B, C ⁄D and E ⁄ F are adjacent coronal brain sections stained by ISH for Vamp1
(A and A¢ higher magniﬁcation), Adcyap1 (C and C¢), Slc17a6 (E and E¢) and Pvalb (B ⁄ B¢, D ⁄ D¢ and F ⁄ F¢). Square delineates the PV1 nucleus shown at higher
magniﬁcation in A¢–F¢. Adjacent horizontal brain sections stained for Pvalb (G and higher magniﬁcation G¢) and Slc17a6 (H and H¢). Scale bar: 200 lm (B), 20 lm
(B¢). Black arrows point to cells co-expressing Pvalb and the tested genes. CTX, cerebral cortex; MN, mammillary nucleus; OT, optic tract; PV1, PV1 nucleus,
highlighted by a dashed line in G; 3V, third ventricle.
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the dentate gyrus revealed the co-existence of several of the genes
found to be expressed in the PV1 nucleus (shown in Fig. 5 for
Serpini1, Kcna2 and Pib5pa). As aforementioned for the PV1 nucleus,
co-expression was not always apparent within all of the visible Pvalb-
expressing cells, and we cannot therefore conclude on the basis of this
study that the candidate genes are universally expressed in all Pvalb-
positive neurons of the investigated areas. By carefully analyzing the
ABA ISH data, we also compared the expression of these genes in the
molecular layer of the cerebellum and the hippocampal stratum oriens,
both containing mainly Pvalb-positive GABAergic interneurons.
Results for the 27 genes are summarized in Table 2. The following
conclusions can be made from these observations. The only genes
speciﬁc for the PV1 nucleus are Slc17a6, Lynx2 and Adcyap1. The
genes Crhr1, Scn4b and Spp1 also show a restricted expression
pattern, being present in both the glutamatergic PV1 neurons and the
GABAergic neurons of the reticular nucleus, but absent from the
Pvalb neurons in all of the other areas analyzed. Several genes are
expressed in virtually all Pvalb cells analyzed (GABAergic and
glutamatergic): Asb13, Gfra1, Hcn2, Kcnc1, Kcna2, Serpini1, Vamp1
and Lynx1 (with the exception of the cerebellum for the ﬁrst four
genes).
Serpini1 and Slc17a7 are expressed in the monkey lateral
tuberal nucleus
On the basis of its topography and neuroanatomy, the lateral tuberal
nucleus (LTN) in primates was previously suggested to correspond to
the PV1 nucleus in rodents (Gerig & Celio, 2007), although
neurochemical homologies have not yet been demonstrated. Indeed,
LTN neurons do not express Pvalb but can be revealed with antibodies
to somatotostatin (Fig. 6A) (Gerig & Celio, 2007). We prepared
M. fascicularis antisense RNA probes to two genes: one marker of the
rodent PV1 nucleus, Serpini1, and one gene encoding vesicular
glutamate transporter VGlut1, Slc17a7 (note that only Slc17a6, not
Slc17a7, was found to be expressed in the mouse PV1, but,
unfortunately, we were unable to obtain probe for Macaca Slc17a6).
As presented in Fig. 6, we found a positive expression for both genes
in the LTN. Although very preliminary, these observations suggest a
possible evolutionary conservation in gene expression between the
rodent PV1 and its putative monkey counterpart, the LTN. In
particular, the expression of Slc17a7 demonstrates that LTN neurons
are also glutamatergic. It will be interesting to analyze the genome-
wide expression proﬁle of the monkey LTN, in order to determine
which of the PV1-expressed genes identiﬁed in this study are
conserved in their expression pattern in the monkey.
Discussion
Several conclusions can be drawn from this study: Pvalb-expressing
neurons of the PV1 nucleus are glutamatergic, excitatory neurons,
which express the Adcyap1 and Nxph4 peptides, but lack classical
hypothalamic neuropeptides (including orexin ⁄ hypocretin), and share
several genes in common with Pvalb-immunoreactive inhibitory,
GABA neurons, found in other brain areas.
According to several transcriptomic studies using gene arrays, very
few of the genes that were found to be expressed in glutamatergic or
Table 2. Summary of co-expression with Pvalb in the hypothalamic PV1 nucleus, thalamic reticular nucleus (RT) and hippocampal dentate gyrus (DG)
Gene
Co-expression with Pvalb in Possible co-expression with Pvalb in
Stratum oriens and molecular layer of
the cerebellumPV1 nucleus DG RT
Adcyap1 Yes NE NE NE NE
Asb13 Yes nt (probable) nt (probable) Yes (few) NE
Cart No NE NE NE NE
Crhr1 Yes NE Yes NE NE
Gad1 No Yes Yes Yes Yes
Gfra1 Yes Yes Yes Yes NE
Hcn2 Yes nt (probable) Yes Yes (few) NE
Kcna2 Yes Yes Yes Yes Yes
Kcnc1 Yes Yes Yes Yes NE
Lynx1 Yes No Yes Yes Yes
Lynx2 Yes No No NE NE
Nefh Yes nt (probable) Yes Yes Yes (few)
Neﬂ Yes Yes Yes Yes (few) Yes (few)
Nef3 Yes nt (probable) Yes Yes (few) Yes (few)
Pdyn No NE NE NE NE
Penk1 No NE NE NE NE
Pib5pa Yes Yes Yes Yes (few) NE
Scn4B Yes NE Yes NE NE
Scrt1 Yes nt (probable) Yes Yes (few) NE
Serpini1 Yes Yes Yes Yes Yes
Slc17a6 Yes No No NE NE
Slc17a7 No Yes No NE NE
Spp1 Yes No Yes NE NE
Tac1 No nt (probable) NE Yes (few) NE
Tac2 No nt (probable) NE NE NE
Trh No NE nt (probable) NE NE
Vamp1 Yes Yes Yes Yes Yes (few)
Yes ⁄ no, experimentally veriﬁed by ISH (this study); nt (probable), not tested experimentally, but probably expressed according to the ABA data; NE, not expressed,
according to the ABA data and our own experimental observations. For the expression in the hippocampal stratum oriens and the molecular layer of the cerebellum,
all data are from the ABA (written in italics).
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Fig. 3. Gene expression in the PV1 hypothalamic nuclei. Higher magniﬁcation of the PV1 nucleus in adjacent sections stained by ISH for Pvalb (A¢, B¢, C¢, D¢, E¢,
F¢, G¢, H¢ and I¢) and Serpini1 (A), Hcn2 (B), Spp1 (C), Pib5pa (D), Kcna2 (E), Scn4b (F), Neﬂ (G), Kcnc1 (H) and Asb13 (I). Black arrows point to cells co-
expressing Pvalb and the different tested genes. Scale bar: 20 lm.
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Fig. 4. Various genes encoding neuropeptides ⁄ neurohormones located in the far basolateral hypothalamus do not co-express with Pvalb in the PV1 nucleus.
Adjacent coronal brain sections stained by ISH for Pvalb (A¢–F¢) and various genes encoding hypothalamic neuropeptides ⁄ neurohormones: Penk1 (A), Cart (B),
Tac1 (C), Pdyn (D), Trh (E) and Tac2 (F). Dashed circles delineate the position of the PV1 nucleus.
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GABAergic neurons (Sugino et al., 2006; Hardt et al., 2008;
Subkhankulova et al., 2010) were revealed from the ABA screen.
The only exceptions were Kcnc1 (a marker for GABAergic cells) and
Nefh and Adcyap1 (reported as typical for glutamatergic cells). Some
of the genes expressed in the PV1 nucleus (listed in Table 1) are
known to occur in subclasses of GABAergic neurons. These include:
Pitx2 (Skidmore et al., 2008; Waite et al., 2011), Scrt (Marin & Nieto,
2006), Scn1a (Ogiwara et al., 2007; Martin et al., 2010), Gfra1(Pozas
& Ibanez, 2005; Canty et al., 2009), Lynx2 (Dessaud et al., 2006) and
Tmem163 (Burre´ et al., 2007). Of the tested genes, only Lynx2,
Slc17a6 and Adcyap1 were expressed exclusively in the glutamatergic
neurons of the PV1 nucleus. These excitatory neurons of the PV1
nucleus thus express many genes in common with inhibitory neurons,
but also very speciﬁc genes. It would be interesting to isolate Pvalb-
positive cells from these different brain areas, and to compare their
transcriptome with microarrays.
The PV1 neurons express several ion channels, including the
potassium channels Kcna2 (Kv1-2), Kcnc1 (Kv3-1) and Hcn2, and the
A′ B′BA
C′C D′D
F′E′E F
Fig. 5. Most of the genes identiﬁed in Pvalb PV1 cells are also expressed with Pvalb in the reticular thalamic nucleus and the dentate gyrus of the hippocampus.
Adjacent coronal brain sections stained by ISH for Pvalb (A¢–F¢) and Serpini1 (A and B), Kcna2 (C and D) and Pib5pa (E and F). Pictures were taken at the level of
the hippocampal dentate gyrus (A–A¢, C–C¢, E–E¢) and reticular thalamic nucleus (B–B¢, D–D¢, F–F¢). Black arrows in panels A-A¢, C-C¢ and E-E¢ highlight cells
double stained for Pvalb and the tested genes. RT, reticular nucleus of the thalamus; VPL, ventrolateral nucleus of the thalamus; VPM, ventromedial nucleus of the
thalamus; st, stria terminalis.
BA C
D E
Fig. 6. Conservation of gene expression in the monkey LTN.Macaca fascicularis brain cryosections hybridized with digoxygenin-labeled antisense RNA probes to
Slc17a7 (B and E) and Serpini1 (C and D). An adjacent section was immunostained with anti-somatostatin to visualize the LTN (A) (marked with dashed line in
A–C). (D and E) Higher magniﬁcations of B and C, focusing on cells stained within the LTN.
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sodium channel Scn4b, and possibly Kcna1 (Kv1-1), Kcnab2,
Kcnab3, Kcnc2 (Kv3-2), Kcnk1 and Scn1a (Nav1-1). Immunohisto-
logical and electrophysiological studies have reported a close
relationship between Pvalb and fast-spiking GABAergic neurons in
the cerebral cortex (Celio, 1986; Kawaguchi & Kondo, 2002). Both
Kv3.1 and Kv3.2 are found in Pvalb cortical interneurons, and play a
crucial role in the generation of the fast-spiking phenotype (Chow
et al., 1999). The presence of the same K+ channels in neurons of the
PV1 nucleus suggests that they also exhibit fast-spiking activity.
Neurons of the PV1 nucleus are devoid of several neuropeptides
typical of LHA, including Tac1 ⁄ 2, Penk1, Pdyn, Trh, Cart (this
study), and orexin, galanin and melanin-concentrating hormone
(Meszar et al., 2011). Adcyap1 is the only exception, together with
Nxph4. Adcyap1, also known as pituitary Adcyap, belongs to the
vasoactive intestinal peptide (VIP) ⁄ glucagon ⁄ growth hormone-releas-
ing factor superfamily. Several functions have been attributed to
Adcyap1, including the control of food consumption, synaptic
plasticity, antinociceptive effects, or hypophysiotrophic activity
(Vaudry et al., 2000). Tracing experiments have shown that PV1
neurons are mostly projecting towards the periaqueductal gray and the
laterodorsal tegmental nucleus (Celio & Saper, 1999). As Adcyap1r,
the gene encoding an Adcyap1 receptor, is expressed in these two
regions (ABA data; see also Vaudry et al., 2000), it could be
suggested that Adcyap1, synthesized from PV1 Pvalb-expressing
neurons, is released into the laterodorsal tegmental nucleus and
periaqueductal gray where it acts by binding to its receptor. Another
neuropeptide used by the PV1 neurons might be Nxph4, a member of
a family of secreted glycoproteins of which another representative,
Nxph1, is expressed primarily in interneurons (Petrenko et al., 1996),
and binds to neurexin1 (Missler & Su¨dhof, 1998). For Nxph4, no
receptor has as yet been identiﬁed.
Spp1 ⁄ osteopontin is a secreted glycoprotein, which binds different
integrin matrix receptors, and exerts several biological activities
including calcium binding, chemotactic effects on astrocytes in the
central nervous system, cell adhesion, cell signaling and cell
proliferation, and regulation of the ECM (Denhardt et al., 2001).
Interestingly, it has an expression pattern in the whole adult mouse
brain that closely mimics that of Pvalb (ABA data). Spp1 has to be
added to the long list of antigens found in the perineuronal net (Celio
& Blumcke, 1994; Celio et al., 1998), a special ECM rich in
proteoglycans and glycoproteins (Bonneh-Karkay & Wiley, 2009).
The Serpini1 brain expression pattern is also very similar to that of
Pvalb. Serpini1 ⁄Neuroserpin is an axonally secreted peptidase
inhibitor of the serpin family. It is believed to be a critical regulator
of extracellular proteolytic events associated with synaptic plasticity
and regeneration, through the inhibition of tissue plasminogen
activator, a major serine protease of the brain ECM (Krueger et al.,
1997; Bonneh-Karkay & Wiley, 2009). The ECM is particularly
accentuated around Pvalb neurons (Meszar et al., 2011). Thus, Spp1
and Serpini1 might be involved in shaping a peculiar ECM around
neurons expressing Pvalb.
Lynx1 and Lynx2 belong to a family of prototoxins that bind to and
regulate the functions of nicotinic acetylcholine receptors, both in vivo
and in vitro (Ibanez-Tallon et al., 2002; Miwa et al., 2006; Tekiney
et al., 2009). Lynx1 ⁄ 2 are glycosylphosphatidylinositol (GPI)-
anchored proteins, which physically associate with their receptors in
the somatodendritic membranes of many neurons (Dessaud et al.,
2006). Neurons of the PV1 nucleus express both Lynx1 and Lynx2
(our ISH data), and possibly Chrnb2 and Chrm2 (ABA data), and
receive Chat-positive terminals (our unpublished data), suggesting that
modulation of cholinergic receptors might be important for their
functioning.
In conclusion, our study illustrates the power of genome-wide ISH
results to generate hypotheses, and the importance of higher resolution
sequential ISH to determine gene batteries expressed in small numbers
of cells in the brain. We expect this approach to be generally
applicable to reﬁning neuroanatomy and gaining functional insight
into other small brain regions.
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